Meet the company trying precision medicine for autism
Swiss biotech Stalicla hopes to bring precision medicine to autism. Experts praise efforts to identify autism subgroups, but evidence to support the company’s claims has yet to be seen.
Swiss biotech Stalicla hopes to bring precision medicine to autism. Experts praise efforts to identify autism subgroups, but evidence to support the company’s claims has yet to be seen.
The cells’ altered proliferation rates hint at ways to diagnose and potentially treat autism earlier.
Implicit biases might be to blame, and the discrepancy persists across clinics, regardless of maternal education, family income and a child’s IQ score.
In this edition, a diagnostic measure shows no significant differences between sexes, and a survey confirms increased gender diversity among children with autism.
Neurona Health, a company in San Francisco, California, backed away from part of its newly launched services after Spectrum started reporting about them.
Two new words and a text swap in the American Psychiatric Association’s diagnostic “bible” are unlikely to affect clinical practice, experts say.
The pandemic has forced many health-care students to train online, raising concerns about their readiness.
Only a quarter of more than 1,000 autism intervention studies published since 1990 report on participants’ races and ethnicities, and just one included a Native American participant.
The fact that autism seems to affect more boys than girls is often attributed to diagnostic gaps, but the skew remains largely unexplained. Some scientists are turning to basic biology for answers.
The connection is likely mediated by environmental, not genetic, factors, according to a new study.